It has been shown that PPAR-α exerts its anti-inflammatory action by negatively influencing the transcriptional activity of NF-кB, and in the absence of PPAR-α gene, IBD pathologies were exacerbated (16). Here, PPARA is linked to irritable bowel syndrome.